Zafgen receives $20.0M in Venture Round funding
Actavis, Forest Labs get second FTC request for merger info
Teva Pharmaceuticals will be releasing its generic version of Celebrex by year's end
Visit our sites for b2b sales and banking employees: cafeb2bsales.com cafebanking.com
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,